NIH Cuts Would Mean Dozens of New Drugs Could Be Lost, CBO Says. That’s Probably an Undercount

Thanks to everyone who weighed in on the future of Cost Curve yesterday. I’m keeping the survey open for another day, so if you haven’t clicked over, I’d be appreciative

It’s a short newsletter today because my attention will be on Washington today. I plan to watch as much of the Senate hearing as I can stand. There’s a lot

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.